Genetic and pharmacological inhibition of SCD1 enhances the ferroptosis induced by erastin and RSL3 [(Wohlhieter et al., 2020)], further highlighting the role of SCD1 in the development of lung cancer and its status as a key regulatory factor in lung cancer stem cells. The gene discussed is SCD; the disease is lung carcinoma.